Last updated: 2026-09-16 10:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Aurora Cannabis Inc. (ACB) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.87, with a market capitalisation of $241.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.56 to $6.67. This page covers its latest market performance, valuation, price trends and company information.
$241.21M | |
$3.82 | |
$3,165.60 | |
$2.56 | |
$3.82 | |
1.01K | |
1.40M | |
-- | |
$6.67 | |
$2.56 | |
-- | |
-- |
Aurora Cannabis Inc. (ACB) is trading at $3.87 in pre-market trading as of 2026-09-16 09:57:00, up 1.41% ($0.05) from the previous close of $3.82
Pre-market trading shows how investors are pricing ACB before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Aurora Cannabis Inc. (ACB) moved from $3.95 to $3.87, representing a decline of 1.92% ($0.08).
The stock traded between $3.68 and $3.97 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 712.91 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 32.0%
ACB is currently trading at $3.87, placing it 32.0% of the way from its 52-week low of $2.56 to its 52-week high of $6.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
| Employees | 1101 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Aurora Cannabis Inc. (ACB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.